SIGA, US Government Ink $113M Procurement Deal for Smallpox, Mpox Drug

SIGA, US Government Ink $113M Procurement Deal for Smallpox, Mpox Drug

Source: 
BioSpace
snippet: 

Oral doses of SIGA Technologies’ antiviral drug Tpoxx will help the U.S. maintain its reserves of the vaccine in preparation for future potential outbreaks, according to the company.